乐普生物股价大跌超过10%,重磅ADC新药上市时间面临推迟

第一财经
04 Mar

3月4日上午,乐普生物(02157.HK)股价开盘后,跌幅一度超过15%,截至十点半左右,股价跌幅仍超过10%,这主要跟公司重磅新药MRG003上市时间面临推迟有关。3月4日早间,乐普生物发布公告解释称,监管机构目前正有序进行MRG003的临床及药学审核。根据公司与监管机构的最新沟通,为补充提交相关资料,公司主动撤回前次MRG003的上市申请。公司已就申报材料进行补充并制备完成eCTD申报文件,将...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10